Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Polymers|December 4, 2020
Experimental and Numerical Investigation of the Extrusion and Deposition Process of a Poly(lactic Acid) Strand with Fused Deposition ModelingAnne Gosset, David Barreiro-Villaverde, Juan Carlos Becerra Permuy, et al.
Pediatrics|April 12, 2006
Reduction in neonatal mortality in Chile between 1990 and 2000Rogelio Gonzalez, Mario Merialdi, Ornella Lincetto, et al.
Sensors (Basel, Switzerland)|July 31, 2019
Introducing Low-Cost Sensors into the Classroom Settings: Improving the Assessment in Agile Practices with Multimodal Learning AnalyticsHector Cornide-Reyes, René Noël, Fabián Riquelme, et al.
British Journal of Clinical Pharmacology|January 11, 2019
Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairmentMuhammad Wasif Saif, Lee Rosen, Michelle A Rudek, et al.
Investigational New Drugs|March 20, 2016
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancersAndrew L Coveler, Andrew H Ko, Daniel V T Catenacci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interferenceNoelle Sevilir Williams, Richard B Gaynor, Shane Scoggin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal CancerRaju Kandimalla, Feng Gao, Takatoshi Matsuyama, et al.
Revista Medica De Chile|June 7, 2003
[Tc99m-pertechnetate thyroid scintigraphy in newborns with congenital hypothyroidism]Gabriel Lobo, David Ladrón de Guevara, Francisca Arnello, et al.
American Journal of Hematology|July 18, 2018
Extended dosing with CC-486 (oral azacitidine) in patients with myeloid malignanciesMichael R Savona, Kathryn Kolibaba, Paul Conkling, et al.
Breast Cancer Research and Treatment|August 18, 2020
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancerJennifer R Diamond, Carlos Becerra, Donald Richards, et al.
Pageof 4